Drug Development stands as a complex yet crucial process, ushering new medications from conception through rigorous research, preclinical testing, clinical trials, and regulatory approvals. This collaborative journey involves researchers, pharmaceutical companies, and regulatory bodies to ensure the safety and efficacy of novel drugs. The landscape of Drug Development includes targeted therapies, biopharmaceuticals, and precision medicine, striving to tailor treatments to individual patient profiles. Technological innovations like high-throughput screening and bioinformatics expedite the discovery of therapeutic agents. As a cornerstone of medical progress, Drug Development plays a pivotal role in addressing unmet medical needs, advancing healthcare, and improving patient outcomes. Key terms associated with Drug Development include preclinical trials, clinical phases, pharmacology, regulatory approvals, and pharmaceutical research. Drug development is conducted under strict ethical and regulatory guidelines to protect patient welfare and ensure the integrity of scientific research. Regulatory compliance is paramount to gaining approvals and maintaining public trust.
Title : Overview of artificial intelligence in healthcare
Adele Webb, Strategic Education, Inc., United States
Title : Will be Updated Soon....
Ismat Mikky, Bloomfield College of Montclair State University, United States
Title : Beyond cultural competence: Integrating cultural intelligence into professional nursing education and practice
Debra A Hrelic, University of North Carolina Wilmington, United States
Title : Experiences of online health information seeking behavior among patients with initial stroke during the transition period in china: A qualitative research
Xiao Yan Dong, Zhengzhou University, China
Title : A call to action for the integration of an underutilized resource: The evidence for Parkinson’s disease and music therapy
Carole Graves, Columbia University School of Nursing, United States
Title : A call to action for the integration of an underutilized resource: The evidence for Parkinson’s disease and music therapy
Klaudia J Zalewska, Columbia University School of Nursing, United States